Short Jay M Phd
Chief Executive Officer at BCAB; Director at SENOMYX INC; Director at INVITROGEN CORP
- Sold, on record
- $13.9M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Dec 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- BCABBioAtla, Inc.Chief Executive Officer
- SENOMYX INCDirector
- INVITROGEN CORPDirector
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- BCAB345,636 shares
- SENOMYX INC23,180 shares
- INVITROGEN CORP19,800 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SENOMYX INCUnusualApr 1, 2014 2014
Sold 11,590 shares at $10.66 ($124k)
Short Jay M Phd, Director
Sold 39.6% of holdings ($312k position)17,678 shares leftFiling
- 2 Form 4 sale SENOMYX INCUnusualOct 1, 2014 +183 days
Sold 7,500 shares at $8.16 ($61k)
Short Jay M Phd, Director
Sold 29.8% of holdings ($205k position)17,678 shares leftFiling
- 3 Form 4 sale BCABPlan not statedJun 16, 2021 +2450 days
Sold 146,137 shares at $40.06 ($5.9M)
Short Jay M Phd, Chief Executive Officer
Sold 14.5% of holdings ($40.5M position)864,602 shares leftFirst sale on recordFiling
- 4 Form 4 sale BCABPlan not statedJun 21, 2021 +5 days
Sold 74,269 shares at $39.16 ($2.9M)
Short Jay M Phd, Chief Executive Officer
Sold 8.6% of holdings ($33.9M position)790,333 shares leftFiling
- 5 Form 4 sale BCABPlan not statedAug 24, 2021 +64 days
Sold 4,533 shares at $41.60 ($189k)
Short Jay M Phd, Chief Executive Officer
Sold 0.6% of holdings ($33.2M position)793,547 shares leftFiling
- 6 Form 4 sale BCABPlan not statedNov 24, 2021 +92 days
Sold 57,640 shares at $25.27 ($1.5M)
Short Jay M Phd, Chief Executive Officer
Sold 4% of holdings ($36.4M position)1.4M shares left0.8x usual sizeFiling
- 7 Form 4 sale BCABPlan not statedNov 29, 2021 +5 days
Sold 15,435 shares at $23.89 ($369k)
Short Jay M Phd, Chief Executive Officer
Sold 1.1% of holdings ($33.1M position)1.4M shares left0.2x usual sizeFiling
- 8 Form 4 sale BCABPlan not statedDec 2, 2021 +3 days
Sold 47,622 shares at $23.48 ($1.1M)
Short Jay M Phd, Chief Executive Officer
Sold 3.5% of holdings ($32.1M position)1.3M shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Dec 7, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 47,622 | $1.1M | 3.5% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 15,435 | $369k | 1.1% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 57,640 | $1.5M | 4.0% | Plan not stated | SEC |
| Aug 24, 2021 | Aug 26, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 4,533 | $189k | 0.6% | Plan not stated | SEC |
| Jun 21, 2021 | Jun 22, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 74,269 | $2.9M | 8.6% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 16, 2021 | BCAB | Chief Executive Officer | Form 4 sale | 146,137 | $5.9M | 14.5% | Plan not stated | SEC |
| Oct 1, 2014 | Oct 3, 2014 | SENOMYX INC | Director | Form 4 sale | 7,500 | $61k | 29.8% | Unusual | SEC |
| Apr 1, 2014 | Apr 2, 2014 | SENOMYX INC | Director | Form 4 sale | 11,590 | $124k | 39.6% | Unusual | SEC |
| Jan 14, 2014 | Jan 16, 2014 | SENOMYX INC | Director | Form 4 sale | 4,090 | $27k | 18.8% | Plan not stated | SEC |
| May 1, 2008 | May 5, 2008 | INVITROGEN CORP | Director | Form 4 sale | 2,500 | $237k | 41.7% | Unusual | SEC |
| Feb 8, 2008 | Feb 12, 2008 | INVITROGEN CORP | Director | Form 4 sale | 13,800 | $1.2M | 44.0% | Unusual | SEC |
| Nov 1, 2007 | Nov 5, 2007 | INVITROGEN CORP | Director | Form 4 sale | 3,500 | $313k | 50.0% | Unusual | SEC |